Total Funding
48
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
43551
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Acquired by 
Vizgen
- David R. Walt: Co-FounderPast Role: Tufts University, University Professor
- Peng Yin: Co-Founder, DirectorPast Role: Harvard Medical School, Assistant Professor of Systems Biology
About the Company
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and will
eventually be valuable for clinical diagnostic use.
